Navigation Links
eCardio Announces Addition to Senior Leadership Team
Date:5/20/2010

HOUSTON, May 20 /PRNewswire/ -- eCardio, one of the leading providers of arrhythmia monitoring solutions, announced today that Thomas Strachan has been added to the senior leadership team in the role of Vice President.  

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100520/DA08439)

"We've expanded our management team to include members with a diverse set of skills ideal for setting new expectations in the remote monitoring industry," noted Robert Jordan, Executive Vice President of eCardio. "With the expansion of our management team and development of technology that exists today, eCardio can better help physicians efficiently manage the data flow required to diagnose and treat their patients."

Strachan joins eCardio from Houston-based Fulbright & Jaworski, L.L.P., where he was responsible for managing litigation practice growth, including implementation of due diligence processes and business development initiatives. Previously, Strachan has held corporate counsel and executive level positions with companies including Bridgeway Software and Kelly Law Registry.

Strachan has a wide range of experience and education in business, corporate law and technology. He earned his Bachelor's degree in Marketing Communications from Temple University and his J.D. from South Texas College of Law.  He is also an Adjunct Professor of Business Law at the University of Houston where he has served for the past eight years.

As Vice President, Strachan will oversee provider business development, lobbying initiatives, academic medicine contracts, and compliance protocols. Thomas will join eCardio's founding executive team, which remains firmly in place to manage the company's principal operations.

About eCardio

eCardio Diagnostics, www.ecardio.com, is one of the nation's leading providers of comprehensive and advanced technologies, devices, services and solutions for the diagnosis, monitoring and subsequent clinical management of cardiac arrhythmias, predominantly in an ambulatory setting.  eCardio provides leading-edge diagnostic innovations and solutions that optimize the flexibility, speed and accuracy of cardiac arrhythmia diagnoses.


'/>"/>
SOURCE eCardio
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Richard Woodyard, Vice President of Sales at eCardio, Loses Fight Against Cancer
2. eCardio Named One of Houstons Fastest Growing Technology Companies at the 2009 Houston Business Journal FastTech 50 Awards Luncheon
3. eCardio Appoints Key Member to Corporate Executive Team
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Australia,s successful biotechnology scientists, Dr Graham ... Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is seeking ... ASX. Noxopharm is a clinic-ready company with its first ... study later this year. NOX66 ... cancer patients - the ability of cancers to become resistant to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... , the only authorized OSHA Training Institute Education Center headquartered in Northern California, ... their workers from extreme heat at their worksites. Employers with workers exposed ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Cut Pro X users can now reveal the media of their split screens ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... California (PRWEB) , ... June ... ... pioneer in the patient payment industry today announced its strategic partnership with ... health system workflows. , The two companies’ proven, proprietary technology combine to ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... technology to revolutionize the emergency ambulance transport experience for the millions of people ... how Uber has disrupted the taxi industry through the use of technology. Now, ...
Breaking Medicine News(10 mins):